161 related articles for article (PubMed ID: 33957632)
1. Evaluation of Acute Central Serous Chorioretinopathy Using Enhanced Depth Imaging Optical Coherence Tomography and Multifocal Electroretinography.
Hong IH; Chang IB; Jeon GS; Han JR
Ophthalmologica; 2022; 245(1):25-33. PubMed ID: 33957632
[TBL] [Abstract][Full Text] [Related]
2. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
3. Correlation between functional and anatomical assessments by multifocal electroretinography and optical coherence tomography in central serous chorioretinopathy.
Yip YW; Ngai JW; Fok AC; Lai RY; Li H; Lam DS; Lai TY
Doc Ophthalmol; 2010 Apr; 120(2):193-200. PubMed ID: 20066472
[TBL] [Abstract][Full Text] [Related]
4. Improvement in multifocal electroretinography after half-dose verteporfin photodynamic therapy for central serous chorioretinopathy: a randomized placebo-controlled trial.
Wu ZH; Lai RY; Yip YW; Chan WM; Lam DS; Lai TY
Retina; 2011; 31(7):1378-86. PubMed ID: 21836413
[TBL] [Abstract][Full Text] [Related]
5. Visual function during and after an acute central serous chorioretinopathy episode.
Kiraly P; Smrekar J; Mekjavić PJ
Doc Ophthalmol; 2022 Aug; 145(1):27-35. PubMed ID: 35608741
[TBL] [Abstract][Full Text] [Related]
6. Central serous chorioretinopathy: risk factors for serous retinal detachment in fellow eyes.
Shinojima A; Mehanna C; Lavia CA; Gaudric A; Tadayoni R; Bousquet E
Br J Ophthalmol; 2020 Jun; 104(6):852-856. PubMed ID: 31473627
[TBL] [Abstract][Full Text] [Related]
7. Morphological and Functional Correlations in Acute Central Serous Chorioretinopathy.
Kiraly P; Šuštar Habjan M; Smrekar J; Jaki Mekjavić P
Doc Ophthalmol; 2024 Jun; 148(3):145-153. PubMed ID: 38498077
[TBL] [Abstract][Full Text] [Related]
8. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
9. Multifocal Electroretinography Changes over 12 Months after Resolution of Central Serous Chorioretinopathy: Prospective Observational Study.
Jeon GS; Chang IB; Ma DJ; Cho IH; Hong IH
Ophthalmic Res; 2023; 66(1):816-823. PubMed ID: 36966538
[TBL] [Abstract][Full Text] [Related]
10. Pattern electroretinography in patients with unilateral acute central serous chorioretinopathy.
Doguizi S; Sekeroglu MA; Ozkoyuncu D; Yilmazbas P
Clin Exp Optom; 2020 Sep; 103(5):656-662. PubMed ID: 31822040
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.
Yang L; Jonas JB; Wei W
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4659-65. PubMed ID: 23737472
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
13. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
[TBL] [Abstract][Full Text] [Related]
14. Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.
Lai TY; Chan WM; Li H; Lai RY; Liu DT; Lam DS
Br J Ophthalmol; 2006 Jul; 90(7):869-74. PubMed ID: 16597666
[TBL] [Abstract][Full Text] [Related]
15. En-face optical coherence tomography hyperreflective foci of choriocapillaris in central serous chorioretinopathy.
Hwang BE; Kim JY; Kim RY; Kim M; Park YG; Park YH
Sci Rep; 2023 May; 13(1):7184. PubMed ID: 37137948
[TBL] [Abstract][Full Text] [Related]
16. Structural Changes of Inner and Outer Choroid in Central Serous Chorioretinopathy Determined by Optical Coherence Tomography.
Sonoda S; Sakamoto T; Kuroiwa N; Arimura N; Kawano H; Yoshihara N; Yamashita T; Uchino E; Kinoshita T; Mitamura Y
PLoS One; 2016; 11(6):e0157190. PubMed ID: 27305042
[TBL] [Abstract][Full Text] [Related]
17. [Differential diagnostic OCT-criteria of acute and chronic central serous chorioretinopathy].
Doga AV; Klepinina OB; Pedanova EK; Mushkova IA
Vestn Oftalmol; 2017; 133(6):10-15. PubMed ID: 29319664
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography.
Yang J; Wang E; Yuan M; Chen Y
Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):241-247. PubMed ID: 31724090
[TBL] [Abstract][Full Text] [Related]
20. Retinal adaptability loss in serous retinal detachment with central serous chorioretinopathy.
Shimada Y; Imai D; Ota Y; Kanai K; Mori K; Murayama K; Yoneya S
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3210-5. PubMed ID: 20164451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
